Clinical Trials Arena October 25, 2024
Akosua Mireku

At the Outsourcing in Clinical Trials Conference, key opinion leaders shared predictions for workflow changes due to AI.

As artificial intelligence (AI) permeates clinical trial operations more than ever, workforces will have to adapt to the changing tides, said experts at the recent Outsourcing in Clinical Trials New England conference.

The event, held from 23–24 October, gathered experts across the clinical trial industry to discuss the evolving landscape of AI in the pharmaceutical sector. “Our industries are terrible at adopting new technology,” says Manny Lazaro, the senior vice president of clinical operations and data management at the neuroscience biotech Cerevel Therapeutics. Lazaro highlighted the falling momentum behind major clinical trends such as decentralised clinical trials and the wave of eCOA...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Biotechnology, Clinical Trials, Conferences / Podcast, Pharma, Pharma / Biotech, Technology, Trends
Related Articles:
How Americans feel about weight-loss drugs, in 3 charts
Drugmakers prep for bird flu outbreak, despite continued low risk
Heart health differences in men and women: Tiny RNA molecules play key role, study finds
Advancing Cancer Care: The Role of Radiopharmaceuticals in Precision Medicine
STAT+: Nobel laureates call on National Academies and biotech CEOs to speak out against Trump attacks on science

Share This Article